Stoke Therapeutics Shares Rise as JPMorgan Initiates Overweight Rating

Stoke Therapeutics shares experienced a rise after JPMorgan initiated coverage of the company with an Overweight rating. This positive analyst rating indicates confidence in the stock's future performance.